Yohimbe - Drug Monograph

Comprehensive information about Yohimbe including mechanism, indications, dosing, and safety information.

Introduction

Yohimbe is an herbal supplement derived from the bark of the Pausinystalia yohimbe tree native to Central Africa. It contains the active alkaloid yohimbine hydrochloride, which has been used traditionally as an aphrodisiac and more recently studied for various medical applications. Unlike FDA-approved pharmaceuticals, yohimbe supplements are marketed as dietary supplements and are not subject to the same regulatory standards.

Mechanism of Action

Yohimbine acts primarily as a selective α₂-adrenergic receptor antagonist. This mechanism:

  • Blocks presynaptic α₂-adrenergic receptors, increasing norepinephrine release
  • Enhances sympathetic nervous system activity
  • Increases parasympathetic cholinergic activity
  • May increase nitric oxide synthesis, contributing to vasodilation
  • These actions collectively result in increased blood flow to certain tissues and potential effects on sexual function

Indications

FDA-approved indication:
  • None for herbal yohimbe supplements
Yohimbine hydrochloride (prescription form) FDA-approved indication:
  • Treatment of erectile dysfunction (not first-line therapy)
Off-label/Traditional uses (not FDA-approved):
  • Sexual dysfunction
  • Weight loss supplement
  • Athletic performance enhancement
  • Depression (limited evidence)

Dosage and Administration

Important: Yohimbe supplements vary significantly in potency and standardization Typical supplement dosing:
  • 5-10 mg of yohimbine hydrochloride equivalent 3 times daily
  • Maximum daily dose: 30 mg
  • Usually administered orally
Special populations:
  • Renal impairment: Use with caution, consider reduced dosing
  • Hepatic impairment: Contraindicated
  • Elderly: Start with lower doses due to increased sensitivity
  • Pediatrics: Not recommended

Pharmacokinetics

Absorption: Rapidly absorbed from GI tract Distribution: Widely distributed throughout body tissues Metabolism: Extensive hepatic metabolism via CYP450 enzymes Elimination: Primarily renal excretion Half-life: Approximately 0.6-2.5 hours Protein binding: Approximately 80%

Contraindications

  • Known hypersensitivity to yohimbine or related compounds
  • Renal disease
  • Hepatic impairment
  • Cardiovascular disease including hypertension, angina, heart failure
  • Psychiatric disorders including anxiety, panic disorders
  • Pregnancy and breastfeeding
  • Concurrent use of antidepressants (especially MAOIs)
  • History of prostate cancer

Warnings and Precautions

  • Black Box Warning: None, but significant safety concerns exist
  • May cause severe hypertension and tachycardia
  • Risk of serotonin syndrome when combined with serotonergic drugs
  • Potential for anxiety, panic attacks, and mood alterations
  • Not recommended for use without medical supervision
  • Quality control issues with dietary supplements may lead to inconsistent dosing

Drug Interactions

Major interactions:
  • MAO inhibitors: Risk of hypertensive crisis
  • SSRIs/SNRIs: Increased risk of serotonin syndrome
  • Antihypertensives: May antagonize effects
  • Sympathomimetics: Additive cardiovascular effects
  • Tricyclic antidepressants: Increased cardiovascular effects
  • CNS depressants: Altered effects
Moderate interactions:
  • Antipsychotics
  • Diabetes medications
  • Other herbal supplements with cardiovascular effects

Adverse Effects

Common (≥1%):
  • Anxiety, nervousness
  • Dizziness
  • Headache
  • Nausea
  • Increased blood pressure
  • Tachycardia
  • Sweating
Serious (<1%):
  • Severe hypertension
  • Cardiac arrhythmias
  • Myocardial infarction
  • Seizures
  • Renal failure
  • Psychiatric symptoms (panic attacks, hallucinations)
  • Serotonin syndrome

Monitoring Parameters

  • Blood pressure (baseline and regularly during use)
  • Heart rate and rhythm
  • Renal function tests
  • Liver function tests
  • Mental status assessment
  • Symptoms of anxiety or panic
  • Sexual function assessment (if used for ED)

Patient Education

  • Yohimbe is not FDA-approved as a dietary supplement
  • Quality and potency may vary significantly between products
  • Report any chest pain, palpitations, or severe anxiety immediately
  • Avoid use if you have any cardiovascular conditions
  • Inform all healthcare providers about yohimbe use
  • Do not combine with other stimulants or antidepressants
  • Discontinue use and seek medical attention if adverse effects occur
  • Not recommended for long-term use without medical supervision

References

1. National Center for Complementary and Integrative Health. Yohimbe. Updated 2020. 2. De Smet PA. Herbal remedies. N Engl J Med. 2002;347(25):2046-2056. 3. Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol. 1998;159(2):433-436. 4. Goldberg MR, Robertson D. Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor. Pharmacol Rev. 1983;35(3):143-180. 5. Natural Medicines Database. Yohimbe. Updated 2023. 6. FDA. Dietary Supplements. Accessed 2023. 7. Kearney T, Tu N. Yohimbine: a clinical review. Pharmacol Ther. 1991;49(1):1-34.

Note: This monograph is for educational purposes only. Yohimbe supplements are not recommended for use without medical supervision due to significant safety concerns and variable product quality.

Medical Disclaimer

The information provided in this article is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

The content on MedQuizzify is designed to support, not replace, the relationship that exists between a patient and their healthcare provider. If you have a medical emergency, please call your doctor or emergency services immediately.

How to Cite This Article

admin. Yohimbe - Drug Monograph. MedQuizzify [Internet]. 2025 Sep 10 [cited 2025 Sep 10]. Available from: http://medquizzify.pharmacologymentor.com/blog/drug-monograph-yohimbe

Enjoyed this post?

Subscribe to our newsletter and get more educational insights, quiz tips, and learning strategies delivered weekly to your inbox.